Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Escalon Medical Corp.
  6. News
  7. Summary
    ESMC   US2960743050

ESCALON MEDICAL CORP.

(ESMC)
Delayed OTC Markets  -  11:46 2022-10-07 am EDT
0.0921 USD   -0.11%
09/28ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
09/28Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
09/28Escalon Medical Corp. Auditor Raises 'Going Concern' Doubt
CI
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Escalon Medical Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2019

05/14/2019 | 04:24pm EDT

Escalon Medical Corp. announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced total revenue was USD 2.668 million compared to USD 2.635 million a year ago. Operating income was USD 22,185 compared to operating loss of USD 92,349 a year ago. Net income was USD 22,205 compared to net loss of USD 119,076 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.02 a year ago. For the nine months, total revenue was USD 7.345 million compared to USD 8.648 million a year ago. Operating loss was USD 247,757 compared to operating Income of USD 125,516 a year ago. Net loss was USD 243,514 compared to net income of USD 531,623 a year ago. Basic loss per share was USD 0.04 compared to basic earnings per share of USD 0.07 a year ago. Diluted loss per share was USD 0.04 compared to diluted earnings per share of USD 0.06 a year ago.


© S&P Capital IQ 2019
All news about ESCALON MEDICAL CORP.
09/28ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
09/28Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
09/28Escalon Medical Corp. Auditor Raises 'Going Concern' Doubt
CI
05/13ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/13Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
02/14ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
02/14Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months En..
CI
2021ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30..
CI
2021Escalon Medical : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
More news
Financials (USD)
Sales 2022 10,7 M - -
Net income 2022 0,02 M - -
Net Debt 2022 0,61 M - -
P/E ratio 2022 -28,0x
Yield 2022 -
Capitalization 0,68 M 0,68 M -
EV / Sales 2021 0,16x
EV / Sales 2022 0,14x
Nbr of Employees 41
Free-Float 98,1%
Chart ESCALON MEDICAL CORP.
Duration : Period :
Escalon Medical Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Richard J. DePiano Chairman, President, CEO & General Counsel
Mark G. Wallace COO, Principal Financial & Accounting Officer
Lisa A. Napolitano Independent Director
C. Todd Trusk Independent Director
David James Jacovini Director
Sector and Competitors